Literature DB >> 17637367

Mycoplasma pneumoniae infection-induced erythema nodosum, anaphylactoid purpura, and acute urticaria in 3 people in a single family.

Yoko Kano1, Yoko Mitsuyama, Kazuhisa Hirahara, Tetsuo Shiohara.   

Abstract

Mycoplasma pneumoniae infection is one of the most common etiologic agents of respiratory tract diseases. Although the respiratory symptoms of this infection commonly are mild, it often is accompanied by various extrapulmonary complications including arthritis and cutaneous manifestations. We report 3 patients with M pneumoniae infection in a single family who revealed erythema nodosum, anaphylactoid purpura, and acute urticaria, respectively. We discuss the similarity between these cutaneous manifestations caused by this infection and those caused by viral infections, and the responsible factors for producing different cutaneous lesions by a single infectious agent in people with common genetic background. Age-related variations in cutaneous manifestations of M pneumoniae infections can be attributed to the immaturity of the adaptive immunity of a host, as has been suggested in viral infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637367     DOI: 10.1016/j.jaad.2005.08.027

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 2.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 3.  Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis.

Authors:  Mitsuo Narita
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

4.  Examination of the Microbial Spectrum in the Etiology of Erythema Nodosum: A Retrospective Descriptive Study.

Authors:  Ozlem Ozbagcivan; Sevgi Akarsu; Ceylan Avci; Burcu Bahar Inci; Emel Fetil
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

5.  Mycoplasma pneumonia with persistent lymphadenopathy and severe cold agglutinin haemolysis.

Authors:  Mit Shah; Sajid Khan; Kenneth Chan
Journal:  Respir Med Case Rep       Date:  2016-10-17

Review 6.  Atypical Bacterial Pathogens and Small-Vessel Leukocytoclastic Vasculitis of the Skin in Children: Systematic Literature Review.

Authors:  Céline Betti; Pietro Camozzi; Viola Gennaro; Mario G Bianchetti; Martin Scoglio; Giacomo D Simonetti; Gregorio P Milani; Sebastiano A G Lava; Alessandra Ferrarini
Journal:  Pathogens       Date:  2021-01-02

7.  Sequentially appearing erythema nodosum, erythema multiforme and Henoch-Schönlein purpura in a patient with Mycoplasma pneumoniae infection: a case report.

Authors:  Masaki Shimizu; Yasuhito Hamaguchi; Takashi Matsushita; Yasuhisa Sakakibara; Akihiro Yachie
Journal:  J Med Case Rep       Date:  2012-11-23

8.  Impact of mycoplasma pneumonia infection on urticaria: A nationwide, population-based retrospective cohort study in Taiwan.

Authors:  Su-Boon Yong; Wei-Chu Yeh; Hsing-Ju Wu; Huang-Hsi Chen; Jing-Yang Huang; Tung-Ming Chang; James Cheng-Chung Wei
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

9.  Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.

Authors:  Yue-Yue Ding; Yan Ren; Jie Qin; Guang-Hui Qian; Yun-Jia Tang; Ye Chen; Xuan Li; Lei Xu; Chun-Hong Qiao; Ling Sun; Hai-Tao Lv
Journal:  World J Pediatr       Date:  2021-06-23       Impact factor: 2.764

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.